Status:
ENROLLING_BY_INVITATION
Genetics of Spontaneous Coronary Artery Dissection (SCAD-INSPIRE Genetics)
Lead Sponsor:
Intermountain Health Care, Inc.
Conditions:
Spontaneous Coronary Artery Dissection
Eligibility:
All Genders
Brief Summary
Spontaneous coronary artery dissection (SCAD) is a rare cause of coronary ischemia and infarction where a tear in blood vessel wall either restricts the flow of blood or the blood becomes trapped in b...
Detailed Description
For this study, we will ascertain clinical data and biological samples from a cohort of SCAD patients identified using retrospective review of medical records and prospective surveillance of Intermoun...
Eligibility Criteria
Inclusion
- SCAD Cases
- Subjects of all ages, gender, or race
- Subjects had coronary angiography.
- Subjects had suspected SCAD as based on clinical report.
- Controls
- INSPIRE subject that had coronary angiography at Intermountain Healthcare for stable angina.
- Subjects had no or mild atherosclerotic heart disease at time of angiography.
- Age at last visit as recorded in the Intermountain EDW at least 50 years or older.
- Not screened as possibly having a SCAD or coronary artery dissection diagnosis.
Exclusion
- SCAD Cases
- Independent review of cardiac imaging and clinical presentation by three cardiologists determine the coronary angiography was not a result of SCAD.
- Imaging from time of coronary angiography of poor quality as to not allow for proper determination of SCAD.
- Inability to determine criteria as outlined above.
- Subjects that have had a heart transplant.
- Subjects that have had a bone marrow transplant.
- Inability or refusal of the patient and/or the patient's legally acceptable representative to provide informed consent or blood sample for any reason.
- Other conditions that in the opinion of the Principal Investigator may increase risk to the subject and/or compromise the quality of the trial.
- Controls
- Subjects that have a heart transplant.
- Subjects that have a bone marrow transplant.
- Subjects with any of the following diagnosis at anytime
- Heart failure
- Heart valve disease
- Thoracic aortic aneurysm and dissection
- Ehlers-Danlos syndrome
- Shprintzen-Goldberg syndrome
- Marfan syndrome
- Loeys-Dietz aortic aneurysm syndrome
- Arterial tortuosity syndrome
Key Trial Info
Start Date :
October 17 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2036
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03876847
Start Date
October 17 2016
End Date
December 31 2036
Last Update
May 24 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.